Clinical trials for Primary cutaneous diffuse large B-cell lymphoma, leg type
3 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPhase 1NCT07368270Safety and Efficacy Study of Anti-PD1 Armored CD19 CAR-T Cells in Adult Subjects With Relapsed or Refractory Diffuse Large B-cell LymphomaJiangsu Topcel-KH Pharmaceutical Co., Ltd.
- RECRUITINGPHASE1, PHASE2NCT07059650DZD8586 Combination Therapy in Patients With Diffuse Large B-cell Lymphoma (TAI-SHAN12)Dizal Pharmaceuticals · PI: Huang
- RECRUITINGPhase 2NCT06570447Glofitamab Combination With Chidamide in Patients With Recurrent/Refractory DLBCLTianjin Medical University Cancer Institute and Hospital